Found 11 matching trials
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
PHASE2Background:
Human papillomavirus (HPV) can cause vulvar high-grade squamou...
Location
National Institutes of Health Clinical Center
E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer
EARLY_PHASE1Background:
More than 12,000 cases of cervical cancer are diagnosed in the...
Location
National Institutes of Health Clinical Center
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
PHASE2Background: Researchers have found a new way to treat cancer. The therapy u...
Location
National Institutes of Health Clinical Center
E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia
PHASE1Background:
Human papillomavirus (HPV) can lead to High-Grade Cervical Int...
Location
National Institutes of Health Clinical Center
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
PHASE2This is a phase II clinical trial to assess the clinical activity of immuno...
Location
National Institutes of Health Clinical Center
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
PHASE1TScan Therapeutics is developing cellular therapies across multiple solid t...
Status
Active Not Recruiting
Location
HonorHealth Research and Innovation Institute
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
PHASE2Background:
The therapy used in this study is called E7 T-cell receptor (T...
Location
National Institutes of Health Clinical Center
Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers
PHASE1This study has 2 parts: Phase 1A and Phase 1B. The primary objectives of Ph...
Location
Banner MD Anderson Cancer Center
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
PHASE1Background:
Human papillomavirus (HPV) can cause cervical, throat, anal, a...
Location
National Institutes of Health Clinical Center
CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
PHASE1A single center, open, single arm dose escalation and dose expansion phase ...
Location
Multiple Locations